Clinical trials
Withdrawn Lupus Erythematosus, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| AbelZeta Inc. | 1 |
| Anthera Pharmaceuticals | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Atara Biotherapeutics | 1 |
| Beijing Boren Hospital | 1 |
| Boehringer Ingelheim | 1 |
| Calibr, a division of Scripps Research | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 43 |
| Lupus Nephritis | 9 |
| Autoimmune Diseases | 5 |
| Myositis | 5 |
| Scleroderma, Systemic | 4 |
| Sjogren's Syndrome | 4 |
| Nephritis | 3 |
| Arthritis, Rheumatoid | 2 |
| Recurrence | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
Trials
Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.